Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of combining Henagliflozin Proline with Metformin XR on body composition in geriatric patients newly diagnosed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Henagliflozin Proline (henagliflozin proline)
  • metformin XR (metformin)

Snippet

Sponsor: Bin Lu | Conditions: Diabetes Type 2 | Phase 4 | Status: NOT_YET_RECRUITING